Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Berral-González

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomolecules|April 30, 2020
Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity CorrelationsMonica M Arroyo, Alberto Berral-González, Santiago Bueno-Fortes, et al.
International Journal of Molecular Sciences|February 10, 2024
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 TumoursGloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, et al.
Scientific Reports|December 27, 2024
Cross-species regulatory network analysis identifies FOXO1 as a driver of ovarian follicular recruitmentAshley E Kramer, Alberto Berral-González, Kathryn M Ellwood, et al.
International Journal of Molecular Sciences|July 14, 2023
Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer CellsNatalia Alonso-Moreda, Alberto Berral-González, Enrique De La Rosa, et al.
Pharmaceutics|November 27, 2025
Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer DrugsAlberto Berral-González, Monica M Arroyo, Diego Alonso-López, et al.
International Journal of Molecular Sciences|January 25, 2025
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell TranscriptomicsEnrique De La Rosa, Natalia Alonso-Moreda, Alberto Berral-González, et al.
Elife|April 24, 2025
RAS-p110α signalling in macrophages is required for effective inflammatory response and resolution of inflammationAlejandro Rosell, Agata Adelajda Krygowska, Marta Alcón Pérez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomolecules|April 30, 2020
Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity CorrelationsMonica M Arroyo, Alberto Berral-González, Santiago Bueno-Fortes, et al.
International Journal of Molecular Sciences|February 10, 2024
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 TumoursGloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, et al.
Scientific Reports|December 27, 2024
Cross-species regulatory network analysis identifies FOXO1 as a driver of ovarian follicular recruitmentAshley E Kramer, Alberto Berral-González, Kathryn M Ellwood, et al.
International Journal of Molecular Sciences|July 14, 2023
Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer CellsNatalia Alonso-Moreda, Alberto Berral-González, Enrique De La Rosa, et al.
Pharmaceutics|November 27, 2025
Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer DrugsAlberto Berral-González, Monica M Arroyo, Diego Alonso-López, et al.
International Journal of Molecular Sciences|January 25, 2025
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell TranscriptomicsEnrique De La Rosa, Natalia Alonso-Moreda, Alberto Berral-González, et al.
Elife|April 24, 2025
RAS-p110α signalling in macrophages is required for effective inflammatory response and resolution of inflammationAlejandro Rosell, Agata Adelajda Krygowska, Marta Alcón Pérez, et al.
Pageof 1